Author Archives: Ana Pena, PhD

GSK Recruiting Lupus Patients to Test Benlysta-Rituximab Combo in Phase 3 Trial

GlaxoSmithKline (GSK) is recruiting participants for a Phase 3 clinical trial to evaluate the effectiveness and safety of Benlysta (belimumab) in combination with rituximab for treating patients with active systemic lupus erythematosus (SLE). The study will evaluate if the treatment combo is better at sustaining low disease activity or remission than Benlysta…